hippuric acid has been researched along with Liver Cirrhosis in 5 studies
hippuric acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #4591
N-benzoylglycine : An N-acylglycine in which the acyl group is specified as benzoyl.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
" In the 7 control subjects, the mean level (+/- SEM) of Cmax for serum benzoate was 104." | 1.28 | Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis. ( Amisaki, T; Fujii, T; Hasegawa, M; Hoshino, U; Kobayashi, J; Suou, T; Tabuchi, F; Takayama, M; Yamada, S; Yamamoto, T, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajaj, JS | 1 |
Cox, IJ | 1 |
Betrapally, NS | 1 |
Heuman, DM | 1 |
Schubert, ML | 1 |
Ratneswaran, M | 1 |
Hylemon, PB | 1 |
White, MB | 1 |
Daita, K | 1 |
Noble, NA | 1 |
Sikaroodi, M | 1 |
Williams, R | 1 |
Crossey, MM | 1 |
Taylor-Robinson, SD | 1 |
Gillevet, PM | 1 |
Poo, JL | 1 |
Cervera, E | 1 |
de Hoyos, A | 1 |
Gil, S | 1 |
Cadena, M | 1 |
Uribe, M | 1 |
LYCZEWSKA, J | 1 |
RAFALOWICZ, A | 1 |
KONDO, T | 1 |
KAWARADA, H | 1 |
YUKITAKE, M | 1 |
Yamada, S | 1 |
Yamamoto, T | 1 |
Suou, T | 1 |
Fujii, T | 1 |
Takayama, M | 1 |
Amisaki, T | 1 |
Tabuchi, F | 1 |
Kobayashi, J | 1 |
Hasegawa, M | 1 |
Hoshino, U | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT01458990] | 60 participants (Actual) | Interventional | 2011-10-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Analysis at baseline will be compared to that at 2 weeks. This will be specifically, changes in those with PPI withdrawal compared to those with PPI initiation (NCT01458990)
Timeframe: 2 weeks
Intervention | Participants (Count of Participants) |
---|---|
PPI Initiation | 0 |
PPI Withdrawal | 0 |
Analysis at baseline will be compared to that at 2 weeks using Multitagged sequencing. Number of patients with overgrowth of oral microbiota in their stool after PPI therapy withdrawal or initiation were specifically analyzed. (NCT01458990)
Timeframe: 2 weeks
Intervention | Participants (Count of Participants) |
---|---|
PPI Inititation | 45 |
PPI Withdrawal | 15 |
1 review available for hippuric acid and Liver Cirrhosis
Article | Year |
---|---|
[Rationale for the use of sodium benzoate in clinical hepatology].
Topics: Acetates; Adult; Animals; Child; Clinical Trials as Topic; Drug Evaluation, Preclinical; Glycine; He | 1990 |
1 trial available for hippuric acid and Liver Cirrhosis
Article | Year |
---|---|
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.
Topics: Arginine; Biomarkers; Case-Control Studies; Feces; Female; Gastrins; Hippurates; Humans; Intestines; | 2014 |
3 other studies available for hippuric acid and Liver Cirrhosis
Article | Year |
---|---|
[EXCRETION OF HIPPURIC ACID AND BENZOYLGLUCURONIC ACID FOLLOWING SODIUM BENZOATE LOAD IN NORMAL SUBJECTS AND IN LIVER DISEASES].
Topics: Benzoates; Biomedical Research; Glucuronates; Hepatitis; Hepatitis A; Hepatolenticular Degeneration; | 1963 |
[ON THE CLINICAL APPLICATION OF HIPPURIC ACID SYNTHESIS TEST (OGATA'S METHOD)].
Topics: Adolescent; Diabetes Mellitus; Hepatitis; Hippurates; Humans; Hypertension; Jaundice; Liver Cirrhosi | 1964 |
Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis.
Topics: Adult; Aged; Benzoates; Benzoic Acid; Chronic Disease; Female; Hepatitis; Hippurates; Humans; Liver | 1992 |